Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback